Manufacturing Scale Up for Clinical Trials
PharmSky Research was contracted by a client to manufacture Phase 1 clinical material of a novel, fatty acid based topical […]
TGA License Granted
Exciting news! Thrilled to share that PharmSky Research have officially received the Therapeutic Goods Administration License. A testament to our commitment to quality and
Sameer Agarwal Appointed to Board of Directors
We’re excited to announce that Sameer Agarwal was recently appointed as a Member of PharmSky’s Board of Directors. Sameer brings
Quantitation of Trace-level Carcinogens Using GC-MS/MS
PharmSky was challenged to detect the three impurities down to trace levels (ppb) for a client interested in the development
PharmSky’s Robust, User-Friendly & Cost-Effective LC Methods
PharmSky was challenged to develop an Analytical Method for a client to characterise a small, polar molecule with poor UV
Ben Boyd Promoted to AAPS Fellow Status
We’re honored to announce PharmSky’s Chief Scientific Consultant Ben Boyd has been elevated by American Association of Pharmaceutical Scientists (AAPS) to Fellow Status. Class of 2023
BIO USA 2023
June 5 – 8 Boston, MA The BIO International Convention attracts 15,000+ biotechnology and pharma leaders for one week of
Clinical Oral Liquid Emulsion for Phase 1 Clinical Trial
Author: Professor Ben Boyd PharmSky have worked with a client to produce a first-in-class oral liquid emulsion high dose MCT
